|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 860 WINTER STREET |
Address2 |
|
City | WALTHAM |
State | MA |
Zip Code | 02451 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 23975-12
|
||||||||
|
6. House ID# 319670000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lois Dehls Cornell, Executive Vice President |
Date | 7/19/2019 10:44:17 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Prescription Drugs
H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs Act
H.R. 2700 - Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act
S. 340, H.R. 965 - Creating and Restoring Equal Access to Equivalent Samples Act of 2019
or the CREATES Act of 2019" - promote competition in the market for drugs and biological products by facilitating the timely entry of entry of lower-cost generic and biosimilar versions of those drugs and biological products
S. 99, H.R. 448 - Medicare Drug Price Negotiation Act
H.R. 275 - Medicare Prescription Drug Price Negotiation Act of 2019
Average Wholesale Price of Pharmaceuticals in Ads - no specific bill
H.R. 2113 Prescription Drug STAR Act - Transparency of pharmaceutical prices across all sectors
Surprise Billing
S. 1895 - Lower Health Care Costs Act
H.R. 3630 - No More Surprises Act
H.R. 3502 - Protecting People From Surprise Medical Bills Act
S. 967 - Resolving Unanticipated Bills Act
Gun Violence
H.R. 8, S. 42 Background Checks of 2019 - Legislation to close loopholes in background checks for guns
S. 184, H.R. 674 Gun Violence Prevention Research Act - Legislation to authorize CDC funds into prevention gun violence research
LABOR-HHS Appropriations to fund gun violence research
Medicare for All
S. 1129 - A bill to establish a Medicare-for-all national health insurance program
H.R.1384 - Medicare for All Act of 2019
S. 470 - Medicare at 50 Act
H.R. 1346 - Medicare Buy-In and Health Care Stabilization Act of 2019
H.R. 1419 - Public Option Deficit Reduction Act
S. 981, H.R.2000 - Medicare-X Choice Act of 2019
ACA Protections
H.R. 2700 - Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act
Physician Burnout - no specific bill
EMR Interoperability & Usability - no specific bill
Social Determinants of Health
Increased federal funds for community-based food programs which provide medically tailored meals to poor, sick, immobile patients and their families - no specific bill
Opioids and Substance Use Disorder
H.R. 2734 - Safer Prescribing of Controlled Substances Act - Federal Prescriber Education Mandates
S. 1365, H.R. 2569 - Comprehensive Addiction Resources Emergency Act of 2019
Federal grants for access to pain experts - no specific bill
Changes to MACRA - no specific bill
Blocking Granting Medicaid - no specific bill
Changes to the Sunshine Act regarding reporting of bulk reprints, textbooks and other peer reviewed education materials - no specific bill
Changes to Title X program - no specific bill
Maternal Mortality
H.R. 2602 - Healthy MOMMIES Act - extending Medicare ACA coverage and access to maternity care
Recommendations to address racial disparities and social determinants in the national maternal mortality crisis
Mental Health
S. 1576, H.R. 2874 - Behavioral Health Coverage Transparency Act
Regulatory Issues
21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program. (RIN: 0955-AA01 CFR:45 CFR Parts 170 and 171; Federal Register Number:2019-02224)
CMS - Problems with prior authorization
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandra |
Calcagno |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Prescription Drugs
H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs Act
H.R. 2700 - Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act
S. 340, H.R. 965 - Creating and Restoring Equal Access to Equivalent Samples Act of 2019
or the CREATES Act of 2019" - promote competition in the market for drugs and biological products by facilitating the timely entry of entry of lower-cost generic and biosimilar versions of those drugs and biological products
S. 99, H.R. 448 - Medicare Drug Price Negotiation Act
H.R. 275 - Medicare Prescription Drug Price Negotiation Act of 2019
Average Wholesale Price of Pharmaceuticals in Ads - no specific bill
H.R. 2113 Prescription Drug STAR Act - Transparency of pharmaceutical prices across all sectors
Surprise Billing
S. 1895 - Lower Health Care Costs Act
H.R. 3630 - No More Surprises Act
H.R. 3502 - Protecting People From Surprise Medical Bills Act
S. 967 - Resolving Unanticipated Bills Act
Gun Violence
H.R. 8, S. 42 Background Checks of 2019 - Legislation to close loopholes in background checks for guns
S. 184, H.R. 674 Gun Violence Prevention Research Act - Legislation to authorize CDC funds into prevention gun violence research
LABOR-HHS Appropriations to fund gun violence research
Medicare for All
S. 1129 - A bill to establish a Medicare-for-all national health insurance program
H.R.1384 - Medicare for All Act of 2019
S. 470 - Medicare at 50 Act
H.R. 1346 - Medicare Buy-In and Health Care Stabilization Act of 2019
H.R. 1419 - Public Option Deficit Reduction Act
S. 981, H.R.2000 - Medicare-X Choice Act of 2019
ACA Protections
H.R. 2700 - Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act
Physician Burnout - no specific bill
EMR Interoperability & Usability - no specific bill
Social Determinants of Health
Increased federal funds for community-based food programs which provide medically tailored meals to poor, sick, immobile patients and their families - no specific bill
Opioids and Substance Use Disorder
H.R. 2734 - Safer Prescribing of Controlled Substances Act - Federal Prescriber Education Mandates
S. 1365, H.R. 2569 - Comprehensive Addiction Resources Emergency Act of 2019
Federal grants for access to pain experts - no specific bill
Changes to MACRA - no specific bill
Blocking Granting Medicaid - no specific bill
Changes to the Sunshine Act regarding reporting of bulk reprints, textbooks and other peer reviewed education materials - no specific bill
Changes to Title X program - no specific bill
Maternal Mortality
H.R. 2602 - Healthy MOMMIES Act - extending Medicare ACA coverage and access to maternity care
Recommendations to address racial disparities and social determinants in the national maternal mortality crisis
Mental Health
S. 1576, H.R. 2874 - Behavioral Health Coverage Transparency Act
Regulatory Issues
21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program. (RIN: 0955-AA01 CFR:45 CFR Parts 170 and 171; Federal Register Number:2019-02224)
CMS - Problems with prior authorization
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandra |
Calcagno |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Opioids and Substance Use Disorder
H.R. 2734 - Safer Prescribing of Controlled Substances Act - Federal Prescriber Education Mandates
S. 1365, H.R. 2569 - Comprehensive Addiction Resources Emergency Act of 2019
Federal grants for access to pain experts - no specific bill
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandra |
Calcagno |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Prescription Drugs
H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs Act
H.R. 2700 - Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act
S. 340, H.R. 965 - Creating and Restoring Equal Access to Equivalent Samples Act of 2019
or the CREATES Act of 2019" - promote competition in the market for drugs and biological products by facilitating the timely entry of entry of lower-cost generic and biosimilar versions of those drugs and biological products
S. 99, H.R. 448 - Medicare Drug Price Negotiation Act
H.R. 275 - Medicare Prescription Drug Price Negotiation Act of 2019
Average Wholesale Price of Pharmaceuticals in Ads - no specific bill
H.R. 2113 Prescription Drug STAR Act - Transparency of pharmaceutical prices across all sectors
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandra |
Calcagno |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
Gun Violence
H.R. 8, S. 42 Background Checks of 2019 - Legislation to close loopholes in background checks for guns
S. 184, H.R. 674 Gun Violence Prevention Research Act - Legislation to authorize CDC funds into prevention gun violence research
LABOR-HHS Appropriations to fund gun violence research
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandra |
Calcagno |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Changes to the Sunshine Act regarding reporting of bulk reprints, textbooks and other peer reviewed education materials - no specific bill
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alexandra |
Calcagno |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |